Navigation Links
microRNA And Its Role In Synaptic Regulation

microRNA belong to the non-coding region of the genome. They play a very important role in regulating the other gene activities like synapses. Researchers at Children's Hospital, Boston says that they are involved in the development of the nervous system.// Synapses are the junctions where the brain cells communicate with each other. This region is very important in the process of developing learning and memory. The findings of this research were published in the journal Nature.

Michael Greenberg, PhD, Director of Neuroscience at Children's Hospital Boston said that this research is one of a kind that helps us to probe into the new mechanism of gene regulation and expression.

Brain has the ability to make or break new synapses thereby adapting itself to the changing environment. It helps in the strengthening the new synaptic junctions and breaking the old unnecessary ones.

Greenberg experimented with animal models such as the rat said that miR-134 (microRNA) helps in altering the size of dendritic spines. Synapses occur at the junction of these dendrites. miR-134 decreases the spine size and weakens the synapse. When miR-134 was inhibited, spines increased in size, strengthening the synapse.

miR-134 is responsible for the inhibition of a gene, Limk1. This causes the growth of the dendritic spines. When neurons were exposed to a growth factor, brain-derived neurotrophic factor (BDNF), Limk1 became active again, enhancing spine growth.

Greenberg believes that the microRNA are responsible in controlling synaptic development. A single neuron can give rise to thousands of synapses. He says that it is very important to be able to control the activities at one synaptic junction without altering the activities at another junction. By doing so a person has the ability to store more information and have increased computational capacity in the brain.

He thinks that this discovery can be put to use in case of treati ng disorders such as mental retardation and autism. It is found that deletion of Limk1 gene is associated with Williams syndrome, and that the alteration of the BDNF pathway all are found in case of patients suffering from tuberous sclerosis and Fragile X syndrome. Research is proved that these three disorders lead to mental retardation and compromised cognition.


'"/>




Related medicine news :

1. Cancer diagnosis easier from microRNA
2. Platelets May Be The Source Of Gene Regulations
3. Novel Rules And Regulations For Cardiovascular Catheterization Labs.
4. Nervous System Plays Role In Stem Cell Regulation
5. Bill for Formal Regulation of Tanning Salons
6. Study Highlights Appetite Regulation Pathway, New Hope for Weight Loss
7. WHO Calls For More Regulation On Tobacco Products
8. Site of Sleep Regulation Identified in Fruit Flies
9. Mechanism of Stem Cell Regulation Identified
10. Natural Approach to Immune Regulation May Help Transplant Patients
11. Regulation of Infertility Clinics Needed
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary ... Work award to iHire in recognition of their exemplary accomplishments in worksite health promotion. ... Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle ... chronic pain and the benefits of holistic treatments, Serenity Recovery Center of ... Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the red ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda ... orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including ... accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... the Clinical Decision Making in Emergency Medicine conference in Ponte Vedra Beach, FL. ... articles published in Emergency Medicine Practice and Pediatric Emergency Medicine Practice. ...
(Date:6/24/2016)... ... , ... National recruitment firm Slone Partners is pleased to announce ... experience, as Vice President of North American Capital Sales at HTG Molecular . ... sales team in the commercialization of the HTG EdgeSeq system and associated reagents in ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
(Date:6/23/2016)... , June 23, 2016 Bracket , a ... its next generation clinical outcomes platform, Bracket eCOA (SM) ... on June 26 – 30, 2016 in Philadelphia ... electronic Clinical Outcome Assessment product of its kind to fully ... Bracket eCOA 6.0 is a flexible platform for ...
Breaking Medicine Technology: